Exosome Diagnostics and Therapeutics Market Dynamics and Trends by 2031

Historic Data: 2021-2022   |   Base Year: 2021   |   Forecast Period: 2024-2031

Exosome Diagnostics and Therapeutics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Diagnostic and Therapeutic), Service (Instrument, Reagents, and Software), End User (Cancer Institutes, Hospitals, Diagnostic Centers, and Others) and Geography

  • Report Date : Aug 2025
  • Report Code : TIPRE00005514
  • Category : Life Sciences
  • Status : Data Released
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The exosome diagnostics and therapeutics market was estimated to be US$ 76.03 Mn in 2021 and US$ xx Bn in 2023. It is expected to reach US$ 1542.45 Mn by 2031 and record a CAGR of 35.1% until 2031. Continued advancements in exosome research and technology, improved isolation techniques, and exosome engineering to enhance therapeutic applications will likely remain key exosome diagnostics and therapeutic market trends.

Exosome Diagnostics and Therapeutics Market Analysis

The increasing prevalence of chronic diseases is expected to grow the exosome diagnostics and therapeutics market. Exosomes are involved in the pathogenesis of diseases, such as cancer, pregnancy disorders, neurodegenerative diseases, and cardiovascular diseases, and are potential non-invasive biomarkers for the diagnosis, prognosis, and therapeutics of a myriad of diseases. As per the European Commission, there were 2.74 million new cancer cases in the EU Member States.

Exosome Diagnostics and Therapeutics Market Overview

The global exosome diagnostics and therapeutics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The market growth in this region is expected due to factors such as increasing demand for novel diagnostic therapeutics, developing overall healthcare infrastructure, and increasing awareness regarding benefits offered by exosome-based diagnostics. However, lack of expertise is likely to restrain the market growth to a certain extent.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Exosome Diagnostics and Therapeutics Market: Strategic Insights

exosome-diagnostic-and-therapeutic-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Exosome Diagnostics and Therapeutics Market Drivers and Opportunities

Rise in Research and Development Activities is Likely to Favor The Market.

Several market players and healthcare organizations are implementing strategies to boost research and development activities on exosome applications. For instance, a research study on ‘Exosomes: Potential Disease Biomarkers and New Therapeutic Targets’ was conducted in the Department of Medicine, Universidad del Norte, Barranquilla, Colombia. The study presented perspectives on the use of exosomes in future clinical practice.

Owing to these factors, exosome diagnostics and therapeutic is gaining importance.

Growing Preference for Non-invasive and Novel Diagnostic Procedure– An Opportunity in Exosome Diagnostics and Therapeutics Market

Exosomes facilitate intercellular communications through the exchange of lipids and proteins between the exosome-producing cells and target cells. Moreover, they enable intracellular communication through the horizontal transfer of biomolecules between cells and their microenvironment. Ongoing research studies have demonstrated the imperative physiological roles of exosomes in the diagnosis of cardiovascular, immune, and neural diseases, as well as in the pathogenesis of chronic conditions such as cancer. A significant number of startups are coming into the market with an aim to fulfill the need of novel invasive diagnostic procedures. For instance, in 2015, a group of researchers launched a new company, Exocan, with the major aim of engaging in the development of an exosomes-based diagnostic platform for accurate and noninvasive diagnosis of cancer with the help of urine and saliva.

Exosome Diagnostics and Therapeutics Market Report Segmentation Analysis

Key segments that contributed to the exosome diagnostics and therapeutics market analysis derivation are services and applications.

  • Based on application, the exosome diagnostics and therapeutics market is segmented into diagnostic and therapeutic applications. In 2023, the diagnostic applications segment held the largest share of the market. Moreover, the therapeutic application segment is expected to grow at the fastest rate during the forecast period.
  • By product, the exosome diagnostics and therapeutics market is segmented into instruments, reagents, and software. The instrument segment held the largest share of the market in 2019, and the software segment is estimated to register the highest CAGR in the market during the forecast period.
  • The exosome diagnostics and therapeutics market has been segmented by end-user into cancer institutes, hospitals, diagnostic centers, and others. In 2023, the cancer institute segment held the largest share of the market by end user. Moreover, the same segment is expected to grow fastest during the forecast period.

Exosome Diagnostics and Therapeutics Market Share Analysis by Geography

The geographic scope of the exosome diagnostics and therapeutics market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America includes the US, Canada, and Mexico. North America holds the most significant share in the exosome diagnostics and therapeutic market, with the US holding the largest market share, followed by Canada. The US holds the largest share of the exosome diagnostics and therapeutics market, which is attributed to increased demand for the use of exosomes as biomarkers in the diagnosis of cancer, along with the increasing prevalence of cancer, the aging population, and lifestyle changes. Additionally, a robust product pipeline, the presence of major players, and well-developed regulatory policies are projected to drive the North American exosome diagnostic and therapeutic market during the forecast period.

Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of the market in the Asia Pacific region is expected to grow at a faster pace owing to factors such as favorable regulatory scenarios, increasing need for superior treatment solutions, and increasing focus on exosome research and development activities. Additionally, expanding healthcare infrastructure and increasing investments in order to boost research activities are projected to drive the Asia Pacific exosome diagnostic and therapeutic market during the forecast period.

Exosome Diagnostics and Therapeutics Market Regional Insights

The regional trends and factors influencing the Exosome Diagnostics and Therapeutics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Exosome Diagnostics and Therapeutics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

exosome-diagnostic-and-therapeutic-market-global-geography
  • Get the Regional Specific Data for Exosome Diagnostics and Therapeutics Market

Exosome Diagnostics and Therapeutics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 76.03 Million
Market Size by 2031 US$ 1542.45 Million
Global CAGR (2023 - 2031) 35.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Diagnostic
  • Therapeutic
By Service
  • Instrument
  • Reagents
  • Software
By End User
  • Cancer Institutes
  • Hospitals
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Aethlon Medical, Inc,
  • Therapeutic Solutions International, Inc,
  • ReNeuron Group plc,
  • Immune Therapy Holdings AB,
  • Cell Guidance Systems LLC,
  • BioRegenerative Sciences,
  • Evomic Science LLC,
  • Norgen Biotek Corp,
  • Exosome Diagnostics, Inc.
  • Bio-Techne,

  • Exosome Diagnostics and Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics

    The Exosome Diagnostics and Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Exosome Diagnostics and Therapeutics Market are:

    1. Aethlon Medical, Inc,
    2. Therapeutic Solutions International, Inc,
    3. ReNeuron Group plc,
    4. Immune Therapy Holdings AB,
    5. Cell Guidance Systems LLC,
    6. BioRegenerative Sciences,

    Disclaimer: The companies listed above are not ranked in any particular order.


    exosome-diagnostic-and-therapeutic-market-cagr

    • Get the Exosome Diagnostics and Therapeutics Market top key players overview

    Exosome Diagnostics and Therapeutic Market News and Recent Developments

    The exosome diagnostics and therapeutics market is evaluated by gathering qualitative and quantitative data post post-primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for exosome diagnostics and therapeutic strategies:

    • In July 2023, Texas–based Direct Biologics announced promising results from a Phase II trial showing that its exosome, ExoFlo, reduced mortality in long COVID patients with acute respiratory distress syndrome. (Source: Company Press Release)
    • In January 2024, EXO Biologics SA, a Belgian biotech company that develops biopharmaceuticals using exosomes to treat rare diseases, launched ExoXpert, a contract development and manufacturing organization (CDMO) specializing in exosomes. (Source: Company Press Release)

    Exosome Diagnostics and Therapeutic Market Report Coverage and Deliverables

    The “Exosome Diagnostics and Therapeutic Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo